Are high-dose statins cost effective for patients after acute coronary syndromes or for patients with chronic coronary disease? Dr. Paul Chan discusses his recent paper in Circulation and his cost-effectiveness analysis.
Are high-dose statins cost effective for patients after acute coronary syndromes or for patients with chronic coronary disease? Dr. Paul Chan discusses his recent paper in Circulation and his cost-effectiveness analysis.
Facebook Comments